Abstract
Testosterone is partially converted to estradiol during the metabolic process. Therefore, it may be pointed out that when testosterone is administered to women, estradiol is increased even though estradiol is not administered, which may increase the risk of uterine cancer and breast cancer. Therefore we report the estradiol level before and after the replacement of Testosterone Enanthate in patients after menopause.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
